Hologic's strong Breast Health segment performance is expected to be a key driver for its fiscal first-quarter 2024 earnings. Despite potential challenges in the Diagnostics and Medical Aesthetics divisions, growth in Breast Health, particularly from the Panther platform, is anticipated to support overall revenue. The company is set to release its Q1 2024 results on January 31, 2024.

豪洛捷

<p>霍洛捷（Hologic）强劲的乳腺健康部门表现预计将成为其 2024 财年第一季度收益的关键驱动力。尽管在诊断和医疗美容部门可能面临挑战，但乳腺健康的增长，特别是来自 Panther 平台的增长，预计将支持整体收入。该公司计划于 2024 年 1 月 31 日发布其 2024 年第一季度的业绩</p>

乳腺健康业务的表现可能有助于提升豪洛捷的第一季度收益